Isolation of cross-reactive human monoclonal antibodies that prevent binding of human noroviruses to histo-blood group antigens

Journal of Medical Virology

Volumn 86, Issue 4, 2014, Pages 558-567

  Higo Moriguchi, Kyoko ^a   Shirato, Haruko ^b   Someya, Yuichi ^b   Kurosawa, Yoshikazu ^a   Takeda, Naokazu ^b,c   Taniguchi, Koki ^a  

^a FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^c MINISTRY OF PUBLIC HEALTH   (Thailand)

Author keywords

Cross reactive; Histo blood group antigen; Human monoclonal antibody; Human norovirus; Phage display

Indexed keywords

CROSS-REACTIVE; HISTO-BLOOD GROUP ANTIGEN; HUMAN MONOCLONAL ANTIBODY; HUMAN NOROVIRUS; PHAGE DISPLAY;

ADULT; AMINO ACID SEQUENCE; ANTIBODIES, BLOCKING; ANTIBODIES, MONOCLONAL; ANTIBODIES, VIRAL; BASE SEQUENCE; BLOOD GROUP ANTIGENS; CALICIVIRIDAE INFECTIONS; CROSS REACTIONS; GASTROENTERITIS; HUMANS; INFANT, NEWBORN; MIDDLE AGED; MOLECULAR SEQUENCE DATA; NOROVIRUS; SEQUENCE ANALYSIS, DNA;

EID: 84893762599     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.23734     Document Type: Article

References (41)

1. Ball JM, Hardy ME, Atmar RL, Conner ME, Estes MK. 1998. Oral immunization with recombinant Norwalk virus-like particles induces a systemic and mucosal immune response in mice. J Virol 72:1345-1353.
2. Batten CA, Clarke IN, Kempster SL, Oliver SL, Bridger JC, Lambden PR. 2006. Characterization of a cross-reactive linear epitope in human genogroup I and bovine genogroup III norovirus capsid proteins. Virology 356:179-187.
3. Bu W, Mamedova A, Tang M, Xia M, Jiang X, Hedge RS. 2008. Structural basis for the receptor binding specificity of Norwalk virus. J Virol 82:5340-5347.
4. Cannon JL, Lindesmith LC, Donaldson EF, Saxe L, Baric RS, Vinjé J. 2009. Herd immunity to GII.4 norovirus is supported by outbreak patient sera. J Virol 83:5363-5374.
5. Cao S, Lou Z, Tan M, Chen Y, Liu Y, Zhang Z, Zhang XC, Li X, Rao Z. 2007. Structural basis for the recognition of blood group trisaccharides by norovirus. J Virol 81:5949-5957.
6. Chachu KA, Strong DW, LoBue AD, Wobus CE, Baric RS, Virgin HW IV. 2008. Antibody is critical for the clearance of murine norovirus infection. J Virol 82:6610-6617.
7. Choi JM, Hustone AM, Estes MK, Prasad BVV. 2008. Atomic resolution structural characterization of recognition of histo-blood group antigens by Norwalk virus. Proc Natl Acad Sci USA 105:9175-9180.
8. Green KY. 2007. Caliciviridae: The noroviruses. In: Knipe DM, Lamb PM, editors-in-chief. Fields virology. 5th edition, Vol. 1. Philadelphia, PA: Liippincott Williams & Wilkins a Wolters. Kluwer Business, pp 949-980.
9. Green KY, Lew JF, Jiang X, Kapikian AZ, Estes MK. 1993. Comparison of the reactivities of baculovirus-expressed recombinant Norwalk virus capsid antigen with those of the native Norwalk virus antigen in serologic assay and some epidemiologic observations. J Clin Microbiol 31:2185-2191.
10. Hale AD, Tanaka TN, Kitamoto N, Ciarlet M, Jiang X, Takeda N, Brown DWG, Estes MK. 2000. Identification of an epitope common to genogroup 1 "Norwalk-like viruses". J Clin Microbiol 38:1656-1660.
11. Hansman GS, Natori K, Shirato-Horikoshi H, Ogawa S, Oka T, Katayama K, Tanaka T, Miyoshi T, Sakae K, Kobayashi S, Shinohara M, Uchida K, Sakurai N, Shinozaki K, Okada M, Seto Y, Kamata K, Nagata N, Tanaka K, Miyamura T, Takeda N. 2006. Genetic and antigenic diversity among noroviruses. J Gen Virol 87:909-919.
12. Harrington PR, Lindesmith L, Yount B, Moe CL, Baric RS. 2002. Binding of Norwalk virus-like particles to ABH histo-blood group antigens is blocked by antisera from infected human volunteers or experimentally vaccinated mice. J Virol 76:12335-12343.
13. Herbst-Kralovetz M, Mason HS, Chen O. 2010. Norwalk virus-like particles as vaccines. Expert Rev Vaccines 9:299-307.
14. Higo-Moriguchi K, Akahori Y, Iba Y, Kurosawa Y, Taniguchi K. 2004. Isolation of human monoclonal antibodies that neutralize human rotavirus. J Virol 78:3325-3332.
15. Huang P, Farkas T, Marionneau S, Zhong W, Ruvoen-Clout N, Marrow AL, Altaya M, Pickering LK, Newburg DS, LePendu J, Jiang X. 2003. Noroviruses bind to human ABO, Lewis, and secretor histo-blood group antigens: Identification of 4 distinct strain-specific patterns. J Infect Dis 188:19-31.
16. Huston AM, Atmar RI, Graham DY, Estes MK. 2002. Norwalk virus infection and disease is associated with ABO histo-blood group type. J Infect Dis 185:1335-1337.
17. Ichihara Y, Matsuoka H, Kurosawa Y. 1988. Organization of human immunoglobulin heavy chain diversity gene loci. EMBO J 7:4141-4150.
18. Jiang X, Wang M, Graham DY, Estes MK. 1992. Expression, self-assembly, and antigenicity of the Norwalk virus capsid protein. J Virol 66:6527-6532.
19. Kageyama TM, Shinohara N, Uchida K, Fukushi S, Hoshino FB, Kojima S, Takai R, Oka T, Takeda N, Katayama K. 2004. Coexistence of multiple genotypes, including newly identified genotypes, in outbreaks of gastroenteritis due to noroviruses in Japan. J Clin Microbiol 42:2988-2995.
20. Kitamoto N, Tanaka T, Natori K, Takeda N, Nakata S, Jiang X, Estes MK. 2002. Cross-reactivity among several recombinant calicivirus virus-like particles (VLPs) with monoclonal antibodies obtained from mice immunized orally with one type of VLP. J Clin Microbiol 40:2459-2465.
21. Kurosawa G, Akahori Y, Morita M, Sumitomo M, Sato N, Muramatsu C, Eguchi K, Matsuda K, Takasaki A, Tanaka M, Iba Y, Hamada-Tsutsumi H, Ukai Y, Shiraishi M, Suzuki K, Kurosawa M, Fujiyama S, Takahashi N, Kato R, Mizoguchi Y, Shamoto M, Tsuda H, Sugiura M, Hattori Y, Miyakawa S, Shiroki R, Hoshinaga K, Hayashi N, Sugioka A, Kurosawa Y. 2008. Comprehensive screening for antigens overexpressed on carcinomas via isolation of human mAbs that may be therapeutic. Proc Natl Acad Sci USA 105:7287-7292.
22. Li X, Zhou R, Wang Y, Sheng H, Tian X, Li H, Qiu H. 2009. Identification and characterization of a native epitope common to norovirus strains GII/4, GII/7, and GII/8. Virus Res 140:188-193.
23. Li X, Zhou R, Tian X, Li H, Zhou Z. 2010. Characterization of a cross-reactive monoclonal antibody against Norovirus genogroups I, II, III, and V. Virus Res 151:142-147.
24. Lindesmith LC, Donaldson EF, LoBue AD, Cannon IL, Zheng D, Vinje J, Baric RS. 2008. Mechanisms of GII.4 norovirus persistence in human populations. PLoS Med 5:e31.
25. Lindesmith LC, Donaldson E, Leon J, Moe CL, Frelinger JA, Johnston RE, Weber DJ, Baric RS. 2010. Heterotypic humoral and cellular immune responses following Norwalk virus infection. J Virol 84:1800-1815.
26. LoBue AD, Lindesmith L, Yount B, Harrington PR, Thompson JM, Johnston RE, Moe CL, Baric RS. 2006. Multivalent norovirus vaccines induce strong mucosal and systemic blocking antibodies against multiple strains. Vaccine 24:5220-5234.
27. Lochridge VP, Jutila KL, Graff JW, Hardy ME. 2005. Epitopes in the P2 domain of norovirus VP1 recognized by monoclonal antibodies that block cell interactions. J Gen Virol 86:2799-2816.
28. Marionneau S, Ruvoën N, Le Moullac-Vaidye B, Clement M, Cailleau-Thomas A, Ruiz-Placois G, Huang P, Jiang X, Le Pendu J. 2002. Norwalk virus binds to histo-blood group antigens present on gastroduodenal epithelial cells of secretor individuals. Gastroenterology 122:1967-1977.
29. Marks JD, Hoogenboom HR, Bonnert TP, McCafferty J, Griffiths AD, Winter G. 1991. By-passing immunization. Human antibodies from V-gene libraries displayed on phage. J Mol Biol 222:581-597.
30. * core of a sialic acid-independent human rotavirus strain. J Virol 80:1513-1523.
31. Ohshima N, Iba Y, Kubota-Kotetsu R, Asano Y, Okuno Y, Kurosawa Y. 2011. Naturally occurring antibodies in humans can neutralize a variety of influenza virus strains, including H3, H1, H2, and H5. J Virol 85:11048-11057.
32. Parker TD, Kitamoto N, Tanaka T, Huston AM, Estes MK. 2005. Identification of genogroup I and genogroup II broadly reactive epitopes on the norovirus capsid. J Virol 79:7402-7409.
33. Parra GI, Abente EJ, Sandoval-Jaime C, Sosnovtsev SV, Bok K, Green KY. 2012. Multiple antigenic sites are involved in blocking the interaction of GII.4 norovirus capsid with ABH histo-blood group antigens. J Virol 86:7414-7426.
34. Reeck A, Kavanagh O, Estes MK, Opekun AR, Gilger MA, Graham DY, Atmar RL. 2010. Serological correlate of protection against norovirus-induced gastroenteritis. J Infect Dis 202:1212-1218.
35. Shiota T, Okame M, Takanashi S, Khamrin P, Takagi M, Satou K, Masuoka Y, Yagyu F, Shimizu Y, Kohno H, Mizuguchi M, Okitsu S, Ushijima H. 2007. Characterization of a broadly reactive monoclonal antibody against norovirus genogroups I and II: Recognition of a novel conformational epitope. J Virol 81:12298-12306.
36. Shirato H. 2011. Norovirus and histo-blood group antigens. Jpn J Infect Dis 64:96-103.
37. Shirato H, Ogawa S, Ito H, Sato T, Kameyama A, Narimatsu H, Xiaofan Z, Miyamura T, Wakita T, Ishii K, Takeda N. 2008. Noroviruses distinguish between type 1 and type 2 histo-blood group antigens for binding. J Virol 82:10756-10767.
38. Tan M, Xia M, Chen Y, Bu W, Hegde RS, Meller J, Li X, Jianf X. 2009. Conservation of carbohydrate binding interfaces - evidence of human HBGA selection in norovirus evolution. PLoS ONE 4:e5058.
39. Tan M, Huang P, Xia M, Fang P, Zhong W, McNeal M, Wei C, Jiang W, Jiang X. 2011. Norovirus P particle: A novel platform for vaccine development and antibody production. J Virol 85:753-764.
40. Yoda T, Terano Y, Suzuki Y, Yamazaki K, Oishi I, Kazuguchi T, Kawamoto H, Utagawa E, Takino K, Oda H, Shibata T. 2001. Characterization of Norwalk virus GI specific monoclonal antibodies generated against Escherichia coli expressed capsid protein and the reactivity of two broadly reactive monoclonal antibodies generated against GII capsid towards GI recombinant fragments. BMC Microbiol 1:24.
41. Yoda T, Suzuki Y, Terano Y, Yamazaki K, Sakon N, Kuzuguchi T, Oda H, Tsukamoto T. 2003. Precise characterization of norovirus (Norwalk-like virus)-specific monoclonal antibodies with broad reactivity. J Clin Microbiol 41:2367-2371.